AngioDynamics
ANGO
158 hedge funds and large institutions have $435M invested in AngioDynamics in 2020 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 58 increasing their positions, 39 reducing their positions, and 28 closing their positions.
49% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 39
12.25% more ownership
Funds ownership: 98.57% → 110.82% (+12%)
11% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 28
1% more funds holding
Funds holding: 157 → 158 (+1)
14% less call options, than puts
Call options by funds: $196K | Put options by funds: $228K
27% less capital invested
Capital invested by funds: $593M → $435M (-$158M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$63M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$5.35M |
| 3 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$3.59M |
| 4 |
Renaissance Technologies
New York
|
+$3.08M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$4.98M |
| 2 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$4.83M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$4.4M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.39M |
| 5 |
Morgan Stanley
New York
|
-$2.26M |
ANGO Hedge Fund Activity: Q1 2020 in Review
158 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2020, worth a combined $435M — down 27% from $593M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new ANGO positions and 28 closed out — a net gain of 3 holders — while 58 added to existing stakes and 39 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $63M. The largest seller was Kennedy Capital Management, exiting entirely with an estimated $4.98M sold.
- 158 institutional investors held AngioDynamics (ANGO) as of Q1 2020, up from 157 in Q4 2019.
- Funds reported $435M of AngioDynamics stock for Q1 2020, down 27% quarter-over-quarter.
- 31 funds opened new AngioDynamics positions in Q1 2020 and 28 closed out, a net change of +3 holders.
- The largest AngioDynamics buyer in Q1 2020 was Victory Capital Management, an estimated $63M added.
- The largest AngioDynamics seller in Q1 2020 was Kennedy Capital Management, an estimated $4.98M sold.
Based on aggregated 13F filings for Q1 2020.